Healthcare Triangle Subsidiary QuantumNexis Reports $20M in Consumption-Based Revenue Processed on Ezovion Platform, Forecasts $37M Amid Rapid Growth
Rhea-AI Summary
Healthcare Triangle (Nasdaq: HCTI) announced that its subsidiary QuantumNexis's Ezovion EMR platform has processed over $20 million in revenue from healthcare providers. The company projects this figure to reach $37 million within six months as it expands into India, Bangladesh, Saudi Arabia, and Malaysia.
QuantumNexis plans to launch a proprietary integrated payment gateway that will generate 0.05% (five basis points) of all revenue processed through the platform. The platform operates on a consumption-based model, enabling healthcare providers to digitize and manage their operations while creating a scalable revenue stream for HCTI through transaction-based fees.
Positive
- None.
Negative
- Payment gateway revenue of 0.05% represents a relatively small percentage of processed transactions
- Payment gateway implementation not expected until late 2025
- International expansion may involve regulatory and operational challenges
News Market Reaction 18 Alerts
On the day this news was published, HCTI gained 11.03%, reflecting a significant positive market reaction. Argus tracked a peak move of +26.6% during that session. Argus tracked a trough of -24.9% from its starting point during tracking. Our momentum scanner triggered 18 alerts that day, indicating notable trading interest and price volatility. This price movement added approximately $2M to the company's valuation, bringing the market cap to $21M at that time. Trading volume was exceptionally heavy at 8.7x the daily average, suggesting very strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
QuantumNexis's Ezovion Electronic Medical Record (EMR) platform has processed over
As QuantumNexis accelerates its global expansion into
Suresh Venkatachari, Chairman of QuantumNexis, said, "Crossing
The Ezovion platform operates on a consumption-based model, scaling alongside its customers as they expand their digital healthcare ecosystems. This approach fosters predictable demand, deeper engagement, and long-term relationships, while setting the stage for future monetization.
Sujatha Ramesh, Chief Operating Officer of Healthcare Triangle Inc, added,
"As customer consumption grows, so does QuantumNexis. The payment gateway enhances this model, unlocking high-volume recurring revenue and positioning HCTI for global scale and long-term value."
Strategic Revenue Transformation: Integrated Payment Gateway Launch
QuantumNexis will soon launch its proprietary integrated payment gateway, representing a pivotal evolution in the company's business model. The gateway will enable QuantumNexis to earn
Kasi Shanmugam, Head of Technology at QuantumNexis,
stated,
"Our gateway has been engineered with advanced security and scalability, seamlessly integrating clinical and financial workflows. This will support rapid, secure adoption as we expand globally."
By embedding payment processing directly into clinical workflows, QuantumNexis eliminates friction for healthcare providers while capturing recurring transaction-based revenue that scales automatically with platform growth.
Strategic Impact for Shareholders
The QuantumNexis milestone and payment gateway launch create multiple value growth drivers for HCTI:
-
$20M + in end-user revenue already processed through the Ezovion platform, demonstrating strong market traction and platform adoption. -
Projected growth to
in end-user revenue within six months, driven by aggressive international expansion and deeping customer engagement with existing customers.$37M - Launch of an integrated payment gateway to directly monetize transaction flows, transforming platform activity into predictable recurring revenue for HCTI.
- Strategic positioning as a hybrid SaaS + fintech company, creating a differentiated investment thesis that appeals to both healthcare technology and fintech-focused institutional investors.
- Initial payment gateway deployments planned for late 2025, with comprehensive global scaling throughout 2026.
David Ayanoglou, Chief Financial Officer of Healthcare Triangle Inc, concluded,
"The rapid increase in end-user revenue processed through Ezovion reflects strong adoption and engagement by healthcare providers. By launching our payment gateway, HCTI can transform this activity into direct, recurring revenue while driving margin expansion and delivering long-term shareholder value."
About Healthcare Triangle
Healthcare Triangle, Inc. based in
Forward-Looking Statements and Safe Harbor Notice :
This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates, forecasts, and projections about the industry and markets in which Healthcare Triangle, Inc. operates, as well as management's beliefs and assumptions. Forward-looking statements include, but are not limited to, statements regarding revenue growth, margin expansion, market opportunities, and strategic initiatives. These statements involve risks, uncertainties, and assumptions that are difficult to predict. Actual outcomes may differ materially from those expressed or implied in any forward-looking statements due to various factors beyond the company's control, including changes in market conditions, client demand, regulatory developments, and execution risks. Readers are cautioned not to place undue reliance on these forward-looking statements. Healthcare Triangle, Inc. undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law
Investors:
1-800-617-9550
ir@healthcaretriangle.com
SOURCE Healthcare Triangle, Inc.